CONTEXT: Maternally inherited 3-kb STX16 deletions cause autosomal dominant pseudohypoparathyroidism type Ib (PHP-Ib) characterized by PTH resistance with loss of methylation restricted to the GNAS exon A/B. OBJECTIVE: The objective of the study was to search for the 3-kb STX16 deletion and to establish haplotypes for the GNAS region for two PHP-Ib patients and their families. SETTING: The study was conducted at a research laboratory and tertiary care hospitals. PATIENTS: The index cases presented at the ages 8 and 9.5 yr, respectively, with hypocalcemia, hyperphosphatemia, and elevated PTH. INTERVENTIONS: There were no interventions. RESULTS: DNA analyses of the index cases revealed an isolated loss of the GNAS exon A/B methylation and the 3-kb STX16 deletion. In the first family, the patient's healthy mother and sister showed no genetic or epigenetic abnormality, yet microsatellite analysis of the GNAS region indicated that both siblings share the same maternal allele, with the exception of an allelic loss for marker 261P9-CA1 (located within STX16), leading to the conclusion that a de novo mutation had occurred on the maternal allele. In the second family, three siblings of the index case are also affected, and an analysis of their DNA revealed the 3-kb STX16 deletion, which was also found in the healthy mother and a maternal uncle. Analysis of the siblings of the deceased maternal grandfather and some of their descendants excluded the 3-kb STX16 deletion, but haplotype analysis of the GNAS region suggested that he had acquired the mutation de novo. CONCLUSIONS: De novo 3-kb STX16 deletions, reported only once previously, are infrequent but should be excluded in all cases of PHP-Ib, even when the family history is negative for an inherited form of this disorder.
CONTEXT: Maternally inherited 3-kb STX16 deletions cause autosomal dominant pseudohypoparathyroidism type Ib (PHP-Ib) characterized by PTH resistance with loss of methylation restricted to the GNAS exon A/B. OBJECTIVE: The objective of the study was to search for the 3-kb STX16 deletion and to establish haplotypes for the GNAS region for two PHP-Ib patients and their families. SETTING: The study was conducted at a research laboratory and tertiary care hospitals. PATIENTS: The index cases presented at the ages 8 and 9.5 yr, respectively, with hypocalcemia, hyperphosphatemia, and elevated PTH. INTERVENTIONS: There were no interventions. RESULTS: DNA analyses of the index cases revealed an isolated loss of the GNAS exon A/B methylation and the 3-kb STX16 deletion. In the first family, the patient's healthy mother and sister showed no genetic or epigenetic abnormality, yet microsatellite analysis of the GNAS region indicated that both siblings share the same maternal allele, with the exception of an allelic loss for marker 261P9-CA1 (located within STX16), leading to the conclusion that a de novo mutation had occurred on the maternal allele. In the second family, three siblings of the index case are also affected, and an analysis of their DNA revealed the 3-kb STX16 deletion, which was also found in the healthy mother and a maternal uncle. Analysis of the siblings of the deceased maternal grandfather and some of their descendants excluded the 3-kb STX16 deletion, but haplotype analysis of the GNAS region suggested that he had acquired the mutation de novo. CONCLUSIONS: De novo 3-kb STX16 deletions, reported only once previously, are infrequent but should be excluded in all cases of PHP-Ib, even when the family history is negative for an inherited form of this disorder.
Authors: Luis Fernández; Pablo Lapunzina; Isidora López Pajares; Germán Rodríguez Criado; Luis García-Guereta; Jesús Pérez; José Quero; Alicia Delicado Journal: Am J Med Genet A Date: 2005-07-01 Impact factor: 2.802
Authors: Guiomar Pérez de Nanclares; Eduardo Fernández-Rebollo; Izortze Santin; Beatriz García-Cuartero; Sonia Gaztambide; Edelmiro Menéndez; Maria Jose Morales; Manuel Pombo; José Ramón Bilbao; Francisco Barros; Nuria Zazo; Wiebke Ahrens; Harald Jüppner; Olaf Hiort; Luis Castaño; Murat Bastepe Journal: J Clin Endocrinol Metab Date: 2007-04-03 Impact factor: 5.958
Authors: J Peters; S F Wroe; C A Wells; H J Miller; D Bodle; C V Beechey; C M Williamson; G Kelsey Journal: Proc Natl Acad Sci U S A Date: 1999-03-30 Impact factor: 11.205
Authors: Agnès Linglart; Robert C Gensure; Robert C Olney; Harald Jüppner; Murat Bastepe Journal: Am J Hum Genet Date: 2005-03-30 Impact factor: 11.025
Authors: Murat Bastepe; Leopold F Fröhlich; Agnès Linglart; Hilal S Abu-Zahra; Katsuyoshi Tojo; Leanne M Ward; Harald Jüppner Journal: Nat Genet Date: 2004-12-12 Impact factor: 38.330
Authors: Giovanna Mantovani; Sara Bondioni; Agnès Linglart; Mohamad Maghnie; Mariangela Cisternino; Sabrina Corbetta; Andrea G Lania; Paolo Beck-Peccoz; Anna Spada Journal: J Clin Endocrinol Metab Date: 2007-06-26 Impact factor: 5.958
Authors: Sihoon Lee; Michael Mannstadt; Jun Guo; Seul Min Kim; Hyon-Seung Yi; Ashok Khatri; Thomas Dean; Makoto Okazaki; Thomas J Gardella; Harald Jüppner Journal: J Bone Miner Res Date: 2015-06-08 Impact factor: 6.741
Authors: Bart L Clarke; Edward M Brown; Michael T Collins; Harald Jüppner; Peter Lakatos; Michael A Levine; Michael M Mannstadt; John P Bilezikian; Anatoly F Romanischen; Rajesh V Thakker Journal: J Clin Endocrinol Metab Date: 2016-03-04 Impact factor: 5.958